Search

Your search keyword '"Antipsychotic Agents urine"' showing total 127 results

Search Constraints

Start Over You searched for: Descriptor "Antipsychotic Agents urine" Remove constraint Descriptor: "Antipsychotic Agents urine"
127 results on '"Antipsychotic Agents urine"'

Search Results

1. Prominently selective fluorescence approach with distinctive biopharmaceutical utility for analysis of lurasidone in human plasma and urine: Application to in vitro dissolution and content uniformity testing.

2. LC-MS-MS Determination of 25 Antipsychotic Drugs and Metabolites in Urine for Medication Compliance Monitoring.

3. Electromembrane extraction of chlorprothixene, haloperidol and risperidone from whole blood and urine.

4. Development of a method of hollow fiber-based solid-phase microextraction followed by ultra performance liquid chromatography-tandem mass spectrometry for determination of five antipsychotics in human whole blood and urine.

5. A Dilute and Shoot LC-MS/MS Method for Antipsychotics in Urine.

6. Sonochemical synthesis of iron-graphene oxide/honeycomb-like ZnO ternary nanohybrids for sensitive electrochemical detection of antipsychotic drug chlorpromazine.

7. Aripiprazole causing false positive urine amphetamine drug screen in an adult patient with bipolar disorder.

8. Lamotrigine Cross-Reactivity With Phencyclidine in Rapid Urine Toxicology in a Research Study.

9. Antipsychotic drug poisoning monitoring of clozapine in urine by using coffee ring effect based surface-enhanced Raman spectroscopy.

10. Clinical Consensus Recommendations for Urine Testing of Adherence to Antipsychotics Among People With Serious Mental Illness.

11. Optimization and Validation of High-Resolution Mass Spectrometry Data Analysis Parameters.

12. Lower rates of consistent urine drug tests for prescribed psychotropic medications among patients on opioid replacement therapy.

13. Quetiapine Carboxylic Acid and Quetiapine Sulfoxide Prevalence in Patient Urine.

14. Case Reports of Aripiprazole Causing False-Positive Urine Amphetamine Drug Screens in Children.

15. Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.

16. Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review.

17. Field-amplified sample injection coupled with pseudo-isotachophoresis technique for sensitive determination of selected psychiatric drugs in human urine samples after dispersive liquid-liquid microextraction.

18. Asenapine (Saphris®): GC-MS method validation and the postmortem distribution of a new atypical antipsychotic medication.

19. Determination of haloperidol in biological samples using molecular imprinted polymer nanoparticles followed by HPLC-DAD detection.

20. An unusual case of risperidone instability in a fatality presenting an analytical and interpretative challenge.

21. Determination of haloperidol in biological samples with the aid of ultrasound-assisted emulsification microextraction followed by HPLC-DAD.

22. Sequential injection chromatography for separation and quantification of chlorpromazine in human urine and pharmaceutical formulations.

23. [The test of benzamide derivative neuroleptics using the technique of thin-layer chromatography].

24. Disposable pipette extraction for the simultaneous determination of biperiden and three antipsychotic drugs in human urine by GC-nitrogen phosphorus detection.

25. Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine.

26. A validated UHPLC-diode array detector method for the bioanalysis of atypical antipsychotics in whole blood, urine and cerebrospinal fluid following SPE.

27. Quantitation of first- and second-generation antipsychotics by LC-MS/MS.

28. Metabolism of a dopamine receptor partial agonist in rats, including an unusual N-dearylation reaction.

29. Sensitive quantification of clozapine and its main metabolites norclozapine and clozapine-N-oxide in serum and urine using LC-MS/MS after simple liquid-liquid extraction work-up.

30. Metabolism and excretion of asenapine in healthy male subjects.

31. Dispersive liquid-liquid microextraction combined with high-performance liquid chromatography for the determination of clozapine and chlorpromazine in urine.

32. False-positive methadone drug screens during quetiapine treatment.

33. Methotrimeprazine-induced corneal deposits and cataract revealed by urine drug profiling test.

34. Atypical antipsychotic metabolism and excretion.

35. Molecularly imprinted polymers as analyte sequesters and selective surfaces for easy ambient sonic-spray ionization.

36. No pharmacokinetic interaction between paliperidone extended-release tablets and trimethoprim in healthy subjects.

37. False negative result for amphetamines on the Triage Drug of Abuse panel? The cause of the unusual phenomenon with experimental analyses.

38. Preliminary evaluation of monolithic column high-performance liquid chromatography with tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection for the determination of quetiapine in human body fluids.

39. Subattomole sensitivity in biological accelerator mass spectrometry.

40. Extraction and determination of trace amounts of chlorpromazine in biological fluids using hollow fiber liquid phase microextraction followed by high-performance liquid chromatography.

41. Determination of sulpiride in human urine using excitation-emission matrix fluorescence coupled with second-order calibration.

42. On-line coupling of solid-phase extraction, derivatization reaction and spectrophotometry by sequential injection analysis: application to trifluoperazine assay in human urine.

43. Metabolic fate of the antipsychotic agent, mazapertine, in man--API-MS and MS/MS identification of urinary metabolites.

44. Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disorders.

45. Electrochemical behavior and determination of clozapine on a glassy carbon electrode modified by electrochemical oxidation.

46. False methadone-positive urine drug screens in patients treated with quetiapine.

47. [Detection of azaleptine in forensic chemical examination of cadaveric material].

48. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry.

49. Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp).

50. Determination of phenothiazines in pharmaceutical formulations and human urine using capillary electrophoresis with chemiluminescence detection.

Catalog

Books, media, physical & digital resources